SMART Path 1.1 Implementation of Innovations

This module enables funding for investments in the establishment or modernization of a production facility to implement the outcomes of research and development (R&D) efforts.

The applicant can implement the results of R&D work that has been conducted independently, commissioned, or purchased earlier. The expectation is to achieve innovation at a minimum on a national level.

The FENG program introduces a new form of funding known as a conditional grant.

The announced competitions have a horizontal nature, enabling entrepreneurs to submit projects on topics that align with the adopted direction of development and market expansion.


Frontline Biosciences expert commentary and recommendations

  • The module can be utilized by both large entrepreneurs and consortium members, including research organizations and non-governmental organizations (NGOs)
  • This represents a noteworthy improvement compared to previous EU funding programs, as it allows not only companies with SME status but also other entities to participate in implementation programs.
  • The Innovation Implementation Module can serve as the foundation for projects carried out by SME companies. Such a project does not have to include the R&D Works Module.
  • The requirements differ for large companies. If a company in this group wishes to undertake the Innovation Implementation Module, they must also incorporate the R&D Works Module within the same project plan.
  • The FENG conditional grant applies only to the Innovation Implementation Module. It assumes partly non-refundable and partly refundable financing on preferential terms. More details are available in an article published by Market Insight.
  • Projects carried out under the Innovation Implementation Module are an extension of the IR OP 1.1.1 “Fast Track” projects, which must be completed by December 2023. When implementing an R&D project supported by a grant, it is important to consider that leveraging another grant can be a beneficial step towards the successful commercialization of the solution.
  • When preparing to participate in the Innovation Implementation Module, it is crucial to give special attention to the reliable documentation of the conducted R&D work. One of the aspects to be verified includes the costs that have already been incurred for the R&D work. Therefore, it is advisable to establish separate accounts specifically designated for recording costs associated with R&D work when engaging in research activities.

Application deadlines

  • GENERAL COMPETITION 27.06.2024 - 24.10.2024

    Program dedicated for general projects in line with KIS (Krajowe Inteligentne Specjalizacje)


    Funding program for projects aiming at improving accessibility


    Call for proposals for projects of a universal nature in line with KIS to be submitted by consortia

Requirements for the applicants

  • Applicants must be classified as either Small and Medium-sized Enterprises (SMEs) or large entrepreneurs.
  • Consortia can be formed exclusively by enterprises or by a combination of enterprises, research organizations, or non-governmental organizations (NGOs)
  • Applicants must demonstrate the innovative nature of the R&D work’s outcomes on a national scale
  • Ability to secure funds to cover the project’s own contribution.
  • Applicants are required to track the market revenue generated from the implementation of the innovation for a period of 4 years following the completion of the project under this module.
  • A module consisting solely of expenses listed under Group I cannot be selected for funding.

Categories of expenditures that are eligible for funding

  • Group I - Physical Resources and Production Space
    • This includes renovation and construction work related to creating space for implementing innovations, as well as the acquisition of developed or undeveloped real estate. 
  • Group II - Production Resources
    • This category comprises fixed assets such as machinery and equipment necessary for implementing the innovation, as well as intangible assets like software and licenses.

Project financing

Project financing

  • 70%

    micro/small enterprises

  • 60%

    medium enterprises

  • 50%

    large enterprises

The level of funding for a project depends on:

  • The size of the enterprise applying for grant funding support.
  • The location of the project (location of the production facility).

Funding provided in the form of a conditional grant: partly non-refundable – partly repayable. The amount of reimbursement is determined four years after the completion of the project under thus module and depends on the amount of revenue generated from the implementation of the innovation on the market.

The level of funding support is determined according to the Regional Aid Map, which serves as a reference. Additionally, the Innovation Implementation Module permits the utilization of de minimis aid.

Each case should be assessed individually since a change in location, such as relocating between two neighboring counties within the same region, can lead to varying levels of funding support for the project.

To determine the level of support available, we recommend reaching out to one of our Subject Matter Experts at Frontline Biosciences SA at: +48 731-995-440 or +48 695-668-436.